Anas Mohamed-Kheir Idris, Suzuki Chie, Yoshioka Koji, Iwamura Shokichi
Department of Production Diseases, Theriogenology Section, National Institute of Animal Health, National Agricultural Research Organization, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0856, Japan.
Reprod Toxicol. 2003 May-Jun;17(3):305-10. doi: 10.1016/s0890-6238(03)00014-5.
The effect of mono(2-ethylhexyl) phthalate (MEHP) on bovine oocyte maturation in vitro was examined. Cumulus-oocyte complexes (COCs) were cultured in maturation medium supplemented with various levels of MEHP for 24h, and then examined for the degree of cumulus expansion and the stage of maturation. A higher percentage of oocytes remained at the germinal vesicle (GV) stage after exposure to 75 and 100 micro M MEHP treatments (13.8 and 44.9% of oocytes, respectively) than the control (2.1% of oocytes). The proportion of oocytes that progressed to the metaphase II (MII) stage was significantly decreased with 25 micro M (59.6% of oocytes), 50 micro M (19.8%), 75 micro M (21.3%), and 100 micro M (3.1%) treatments than the control (77.3%). MEHP did not affect the process of cumulus expansion. For denuded oocytes, MEHP treatment of 50-100 micro M resulted in a significantly higher rate of oocytes remained at the GV stage compared to the control (53.4, 80.2, 88.4, and 5.4%, respectively). The rate of MII formation was significantly decreased with 10 micro M (60.9%) and 25 micro M (22.5%) MEHP treatments compared to control (68.9%). Furthermore, with 50, 75 or 100 micro M MEHP, no oocyte reached the MII stage. When COCs were cultured for 24h with 50 or 100 micro M MEHP and then cultured for an additional 24h in MEHP-free medium, most of the oocytes reached the MII stage (71.1 and 64.5%, respectively).Taken together, these results indicate that MEHP, at doses lower than those reported in blood transfusion patients, could negatively modulate bovine oocyte meiotic maturation in vitro, suggesting possible risks for human and other mammalians reproductive health.
研究了邻苯二甲酸单(2-乙基己基)酯(MEHP)对牛卵母细胞体外成熟的影响。将卵丘-卵母细胞复合体(COCs)在添加不同水平MEHP的成熟培养基中培养24小时,然后检查卵丘扩展程度和成熟阶段。与对照组(2.1%的卵母细胞)相比,暴露于75和100微摩尔MEHP处理后(分别为13.8%和44.9%的卵母细胞),处于生发泡(GV)期的卵母细胞百分比更高。与对照组(77.3%)相比,25微摩尔(59.6%的卵母细胞)、50微摩尔(19.8%)、75微摩尔(21.3%)和100微摩尔(3.1%)处理的卵母细胞进入中期II(MII)期的比例显著降低。MEHP不影响卵丘扩展过程。对于裸卵,与对照组相比(分别为53.4%、80.2%、88.4%和5.4%),50-100微摩尔的MEHP处理导致处于GV期的卵母细胞比例显著更高。与对照组(68.9%)相比,10微摩尔(60.9%)和25微摩尔(22.5%)的MEHP处理显著降低了MII形成率。此外,在50、75或100微摩尔MEHP处理下,没有卵母细胞达到MII期。当COCs在含有50或100微摩尔MEHP的培养基中培养24小时,然后在不含MEHP的培养基中再培养24小时时,大多数卵母细胞达到MII期(分别为71.1%和64.5%)。综上所述,这些结果表明,低于输血患者报告剂量的MEHP可能会在体外对牛卵母细胞减数分裂成熟产生负向调节作用,提示对人类和其他哺乳动物生殖健康可能存在风险。